Shanghai Haohai Biological Tech Co - Asset Resilience Ratio

Latest as of September 2025: 1.51%

Shanghai Haohai Biological Tech Co (688366) has an Asset Resilience Ratio of 1.51% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥107.18 Million

≈ $15.68 Million USD Cash + Short-term Investments

Total Assets

CN¥7.12 Billion

≈ $1.04 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2024)

This chart shows how Shanghai Haohai Biological Tech Co's Asset Resilience Ratio has changed over time. Check Shanghai Haohai Biological Tech Co PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Haohai Biological Tech Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Shanghai Haohai Biological Tech Co market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥107.18 Million	1.51%
Total Liquid Assets	CN¥107.18 Million	1.51%

Asset Resilience Insights

Limited Liquidity: Shanghai Haohai Biological Tech Co maintains only 1.51% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shanghai Haohai Biological Tech Co Industry Peers by Asset Resilience Ratio

Compare Shanghai Haohai Biological Tech Co's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Prostemics Co. Ltd KQ:203690	Biotechnology	0.31%
ORUM KQ:475830	Biotechnology	82.74%
TELIX Pharmaceuticals Ltd AU:TLX	Biotechnology	32.29%
TG Therapeutics Inc NASDAQ:TGTX	Biotechnology	4.72%
Green Cross Holdings Preference Shares KO:005257	Biotechnology	0.50%
Rocket Pharmaceuticals Inc NASDAQ:RCKT	Biotechnology	33.70%
NEWRON PHARMACEUT. EO-20 XETRA:NP5	Biotechnology	41.67%
Cybin Inc NEO:CYBN	Biotechnology	0.21%

Annual Asset Resilience Ratio for Shanghai Haohai Biological Tech Co (2012–2024)

The table below shows the annual Asset Resilience Ratio data for Shanghai Haohai Biological Tech Co.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	1.23%	CN¥87.85 Million ≈ $12.85 Million	CN¥7.12 Billion ≈ $1.04 Billion	+1.07pp
2023-12-31	0.17%	CN¥11.76 Million ≈ $1.72 Million	CN¥7.11 Billion ≈ $1.04 Billion	+0.07pp
2022-12-31	0.10%	CN¥6.75 Million ≈ $987.58K	CN¥6.89 Billion ≈ $1.01 Billion	+0.01pp
2021-12-31	0.09%	CN¥6.38 Million ≈ $933.01K	CN¥6.95 Billion ≈ $1.02 Billion	-0.15pp
2020-12-31	0.24%	CN¥15.14 Million ≈ $2.22 Million	CN¥6.30 Billion ≈ $921.70 Million	-1.59pp
2018-12-31	1.83%	CN¥81.28 Million ≈ $11.89 Million	CN¥4.44 Billion ≈ $649.18 Million	+0.69pp
2013-12-31	1.14%	CN¥7.09 Million ≈ $1.04 Million	CN¥621.18 Million ≈ $90.90 Million	-0.42pp
2012-12-31	1.56%	CN¥7.00 Million ≈ $1.02 Million	CN¥448.04 Million ≈ $65.56 Million	--

pp = percentage points

About Shanghai Haohai Biological Tech Co

SHG:688366 China Biotechnology

Market Cap

$865.32 Million

CN¥5.91 Billion CNY

Market Cap Rank

#9528 Global

#2412 in China

Share Price

CN¥31.09

Change (1 day)

-1.96%

52-Week Range

CN¥28.61 - CN¥57.62

All Time High

CN¥268.82